Related Experiment Video
Updated: Jun 28, 2026
08:31
Place and Response Learning in the Open-field Tower Maze
Published on: October 28, 2015
Life-time estrogen exposure and cognitive functioning in later life
Joanne Ryan1, Isabelle Carrière2, Jacqueline Scali2
1Inserm, U888, Montpellier F-34093, France; Univ Montpellier1, Montpellier F-34000, France; Department of Psychiatry, The University of Melbourne, Melboure, Australia.
Psychoneuroendocrinology
|October 25, 2008
Summary
Lifetime estrogen exposure factors, like age at first menses, are linked to cognitive function in older women. While hormone therapy showed some benefits, lifetime reproductive history did not predict dementia risk over four years.
Area of Science:
- Neuroscience
- Endocrinology
- Gerontology
Background:
- Exogenous estrogen's effect on cognitive decline and dementia is inconsistent.
- Limited research exists on lifetime estrogen exposure's impact on cognition.
- Lifetime estrogen exposure may influence cognitive function and treatment response.
Purpose of the Study:
- To investigate associations between lifetime estrogen exposure factors and cognitive function in postmenopausal women.
- To explore how reproductive history influences cognitive performance in later life.
- To determine if lifetime hormonal factors modulate response to hormone therapy.
Main Methods:
- A population-based cohort of 996 French women (aged 65+) was studied.
- Cognitive tests were administered at baseline and at 2 and 4 years.
- Detailed reproductive histories were collected and analyzed using logistic regression.
Main Results:
- Earlier age at first menses correlated with poorer visual memory and psychomotor speed.
- Longer reproductive period associated with better verbal fluency.
- Early first childbirth linked to worse performance across multiple cognitive domains.
Conclusions:
- Lifetime hormone-related events, beyond hormone therapy, are associated with cognitive function in older women.
- This study did not find lifetime reproductive variables to be associated with dementia risk over 4 years.
- Further research is needed to confirm dementia risk associations and explore hormone therapy response modulation by lifetime hormonal exposure.
More Related Videos
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...